ASX Announcement

Dose finding complete in ADVENT-AML Phase 1b clinical trial

Published: 24/10/24, 09:55am (AEST)3 pages
Chimeric Therapeutics
CHM:ASXHealthcare

Recent CHM Announcements

Price Sensitive only